Lipiflow
Lipiflow is a medical device with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
TearCare System to Treat Dry Eye Disease
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction
Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye
Treatment Regimens in Meibomian Gland Dysfunction
Clinical Trials (8)
TearCare System to Treat Dry Eye Disease
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction
Comparison of Non-pharmaceutical Treatments for Evaporative Dry Eye
Treatment Regimens in Meibomian Gland Dysfunction
Meibomian Gland Dysfunction Treatment
Clinical Effect of MiboFlo in Dry Eye Patients
Comparison of Lipiflow®-Treatment and a Standard Lid Hygiene Regime
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8